1. Home
  2. REVB vs AUUD Comparison

REVB vs AUUD Comparison

Compare REVB & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$1.07

Market Cap

4.2M

Sector

Health Care

ML Signal

HOLD

Logo Auddia Inc.

AUUD

Auddia Inc.

HOLD

Current Price

$1.42

Market Cap

4.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
REVB
AUUD
Founded
2020
2012
Country
United States
United States
Employees
9
5
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REVB
AUUD
Price
$1.07
$1.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
56.1K
5.4M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$0.51
52 Week High
$3.21
$10.10

Technical Indicators

Market Signals
Indicator
REVB
AUUD
Relative Strength Index (RSI) 48.96 43.35
Support Level $1.06 $0.74
Resistance Level $1.20 $1.49
Average True Range (ATR) 0.05 0.26
MACD 0.01 0.02
Stochastic Oscillator 78.87 17.73

Price Performance

Historical Comparison
REVB
AUUD

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

About AUUD Auddia Inc.

Auddia Inc is a United States-based company. It operates through its proprietary AI platform for audio and is reinventing not only how consumers engage with AM/FM radio, podcasts, and other audio content but also how artists and labels promote their music and gain access to mainstream radio audiences. The group Discovr Radio is the first music-promotion platform to deliver artists guaranteed exposure to radio listeners. Its flagship audio superapp, called faidr, delivers multiple industry firsts, including: Ad-free listening on any AM/FM radio station, Content skipping across any AM/FM station, One-touch skipping of entire podcast ad breaks, and Integrated artist discovery experiences.

Share on Social Networks: